Momo Vuyisich
Founding Chief Science Officer and Head of Clinical Research Viome
Seminars
Wednesday 11th November 2026
Optimizing LBP & FMT Commercialization Models to Identifying Sustainable Microbiome Growth Strategies
9:00 am
- Evaluating consumer commercialization approaches to identifying scalable market adoption strategies for LBP & FMT developers
- Assessing reimbursement-driven therapeutic models to determining long-term revenue generation opportunities across microbiome markets
- Identifying customer engagement techniques to strengthening awareness, retention & downstream therapeutic demand
